BVI to launch new SERENITY and SERENITY Toric monofocal IOLs

News
Article

The new, non-diffractive IOLs are the second generation of BVI’s ISOPURE premium monofocal IOL that was launched in 2019.

Doctor performing cataract surgery Image credit: AdobeStock/Kate

Image credit: AdobeStock/Kate

Ophthalmic device company BVI has announced that its new SERENITY and SERENITY Toric premium monofocal IOLs will be fully commercial available in CE-accepting markets in 2025.1 The new, non-diffractive IOLs are the second generation of BVI’s ISOPURE premium monofocal IOL that was launched in 2019, according to a news release.

“As we launch the second-generation SERENITY and SERENITY Toric IOLs, BVI views this IOL as potentially a game-changer when it comes to standard of care for monofocal procedures,” said Shervin Korangy, president and CEO of BVI, in the release. “Our portfolio includes a wide range of IOLs, meticulously designed from material to haptics to optics to provide the optimal outcome without the burden of retro-fitting legacy predicate devices.”

The IOL also features ISOFOCAL optic technology to aid in clear distance vision and intermediate vision by balancing depth of focus and image quality. This allows the lens to provide far vision equal to a monofocal but with adequate intermediate vision up to 66 cm. Additionally, the lens’ double c-loop POD platform is specifically designed to deliver precise astigmatism correction and stable IOL positioning, according to the release. Those with astigmatism benefit with stability in the capsular bag, which results in outcomes accurately predicted by BVI’s toric calculator.1

The SERENITY series’ ISOFOCAL technology also works in favor of stability by delivering spherical aberration correction across the entire optic diameter and customizable levels of spherical aberration per dioptric power, the release said.

Sheraz Daya, MD, FACP, FACS, FRCS(Ed), FRCOphth, of Centre For Sight, UK, was 1 of the first surgeons to implant SERENITY. “It is wonderful to see this increased range of focus lens on the same platform as the Finevision with 4 C loop haptics,” he said in the release. “I look forward to the Toric version as well which I know will be very stable with no rotation.”

BVI plans to launch the new IOL during the 2024 European Society of Cataract and Refractive Surgeons meeting in Fira de Barcelona, Spain from September 6-10.

Reference:
  1. BVI to launch new SERENITY and SERENITY toric premium monofocal IOLs. News release. BVI. September 3, 2024. Accessed September 4, 2024. https://www.bvimedical.com/us/bvi-to-launch-new-serenity-and-serenity-toric-premium-monofocal-iols/
Recent Videos
Optometrists reflect on their residency experiences and provide advice to current residents.
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
© 2024 MJH Life Sciences

All rights reserved.